This discovery opened up the possibility of investigating changes in Rab10 phosphorylation in PD patients, although a more high-throughput assay (e.g. ELISA) rather than immunoblotting would be required for undertaking a large-scale comparison between healthy elderly individuals and PD patients. This evidence concerns the gene RAB10 and Parkinson disease.